CEO of Samen Pharmaceutical Co., today Saturday, March 25th, in the unveiling ceremony of the drug “Injectable Acetaminophen”, which was attended by Grand Custodian of Astan Quds Razavi and held in the company, said “‘Injectable Acetaminophen’, with ‘Thamostamol’ brand for the first time in Iran, by Samen Pharmaceutical Co., is mass-produced. It is appropriate for direct use intravenously and to reduce and control the mild and moderate pain, and also reducing fever especially after surgery.”
Ebrahim Din Mohammadi, pointing to the measures taken by Samen Company in the field of recombinant drugs, stated, “Samen Pharmaceutical Company entering the production field of recombinant drugs, and reducing the country's dependence on foreign drugs, is an endeavor to realize Resistive Economy’s policies.”
“Since the beginning of the 1395 Hijri so far, in all foreign contracts, the necessity for technology transfer to the country is emphasized, and no contract shall be made unless this is included in it” he added.
CEO of Samen Company, introduced producing “Injectable Acetaminophen”, the result of collaboration with the University of Shiraz, and said “One of the principles of the Samen Pharmaceutical Company is maintaining the relation between industry and universities, and in this regard, over the last year, twenty skilled and educated academics have been absorbed by the Company.”
He, highlighting that the Samen Company in 1395/2016, is recognized as the top entrepreneur by the Department of Cooperatives, Labor and Social Welfare of Khorasan Razavi Province said, “Last year, the company’s exports increased from two countries to seven.”
“Samen Pharmaceutical Company, under the graciousness of Imam Ali ibn Musa al-Reza (A.S.), stepped on the way to meet the pharmaceutical needs of the country, and has always tried to move in line with the Septet Charter of the Supreme Leader for Astan Quds Razavi, to create employment, eliminating deprivation, and materializing the country's development and prosperity” Din Mohammadi said in the end.
